Gewinn- und Verlustrechnung von Axon Enterprise, Inc.

Wall Street says AppLovin and Axon Enterprise are the best Nasdaq-100 stocks to buy now.

MassMutual Private Wealth and Trust FSB boosted its stake in shares of Axon Enterprise, Inc (NASDAQ: AXON) by 122,993.6% during the undefined quarter, according to its most recent 13F filing with the SEC. The firm owned 461,601 shares of the biotechnology company's stock after buying an additional 461,226 shares during the period. Axon

In the latest trading session, Axon Enterprise (AXON) closed at $413.35, marking a -2.1% move from the previous day.

ARKX delivers higher returns but charges double the fees and carries greater volatility. XAR offers lower costs and broader diversification across 50 holdings.

Axon (AXON) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Axon Enterprise (AXON) closed at $430.11 in the latest trading session, marking a -3.35% move from the prior day.

In the closing of the recent trading day, Axon Enterprise (AXON) stood at $450.61, denoting a -1.9% move from the preceding trading day.

Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.

Axon Enterprise (NASDAQ: AXON - Get Free Report) and Arxis (NASDAQ: ARXS - Get Free Report) are both large-cap industrials companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, risk, dividends, institutional ownership and profitability. Analyst Ratings This is a summary of recent

Axon offers compelling risk-reward after a misunderstood 0% $1B convertible note, with minimal dilution risk and strategic capital flexibility. Q2 FY26 saw robust 35% YoY revenue growth, strong software momentum, and raised 2024 revenue guidance to 32-34%, despite near-term margin noise. Dilution from the convertible is capped unless AXON exceeds $1,049.94/share by 2031; capped call structure and cash settlement options further protect shareholders.